| 名稱 | AI-Edigene® EGFR p.L861Q Reference Standard P |
| 型號(hào) | CBP10401 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | AI-Edigene® EGFR p.L861Q Reference Standard Plus |
產(chǎn)品搜索
相關(guān)文章
- 羅氏乳腺癌新藥獲英國(guó)NICE批準(zhǔn)用于HER2乳腺癌新輔助治療
- 能量平衡的重要靶點(diǎn)——CRF1R和CRF2R
- ATCC細(xì)胞系中的遺傳物質(zhì)你了解多少？
- JCI：中山大學(xué)科學(xué)家找到可能*治愈常見(jiàn)白血病的新靶點(diǎn)
- CD74-ROS1的藥靶模型+DNARNA標(biāo)準(zhǔn)品+ddPCR試劑盒
- BCMA靶點(diǎn)藥物細(xì)胞篩選模型
- 核酸診斷新型冠狀病毒——假病毒標(biāo)準(zhǔn)品
- 肥胖與腫瘤治療新星靶點(diǎn)——GDF15-GFRAL
- 【產(chǎn)品推介】LAG-3靶點(diǎn)細(xì)胞篩選模型
- 細(xì)胞株的核型分析實(shí)驗(yàn)操作流程分析
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Mutation > CBP10401AI-Edigene® EGFR p.L861Q Reference Standard P
- 詳細(xì)內(nèi)容
" _ue_custom_node_="true">
CBP10401 | |
| Format | Genomic DNA |
| Description | The L861Q mutation results in an amino acid substitution at position 861 in EGFR, from a leucine (L) to a glutamine (Q). This mutation occurs within exon 21, which encodes part of the kinase domain, and occurs with a frequency of approximately 2% in EGFR-mutated lung tumors (Mitsudomi and Yatabe 2010). This mutation is associated with increased sensitivity to the EGFR TKIs, erlotinib (Tarceva) and gefitinib (Iressa; Lynch et al. 2004). |
| Technical Data | |
| DNA Change | c.2582T>A |
| AA Change | p.L861Q |
| Mutation type | Substitution - Missense |
| Zygosity | Homozygous |
| Allelic Frequency | 100% |
| Transcript | ENST00000275493 |
| Cosmic ID | COSM6213 |
| Chr position(GRCh37) | chr7:55259524 |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)